Head to Head Review: OptimizeRx (NASDAQ:OPRX) & CFN Enterprises (OTCMKTS:CNFN)

OptimizeRx (NASDAQ:OPRXGet Free Report) and CFN Enterprises (OTCMKTS:CNFNGet Free Report) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, analyst recommendations, institutional ownership, risk and valuation.

Earnings and Valuation

This table compares OptimizeRx and CFN Enterprises”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
OptimizeRx $92.13 million 1.65 -$17.57 million ($1.10) -7.52
CFN Enterprises $3.54 million 8.13 -$15.19 million ($0.19) -1.84

CFN Enterprises has lower revenue, but higher earnings than OptimizeRx. OptimizeRx is trading at a lower price-to-earnings ratio than CFN Enterprises, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares OptimizeRx and CFN Enterprises’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OptimizeRx -27.41% -4.92% -3.41%
CFN Enterprises -67.36% N/A -53.19%

Analyst Recommendations

This is a breakdown of current ratings and price targets for OptimizeRx and CFN Enterprises, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OptimizeRx 0 3 5 1 2.78
CFN Enterprises 0 0 0 0 0.00

OptimizeRx currently has a consensus price target of $9.06, suggesting a potential upside of 9.58%. Given OptimizeRx’s stronger consensus rating and higher probable upside, equities analysts clearly believe OptimizeRx is more favorable than CFN Enterprises.

Insider & Institutional Ownership

76.5% of OptimizeRx shares are held by institutional investors. 6.1% of OptimizeRx shares are held by insiders. Comparatively, 40.8% of CFN Enterprises shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Risk & Volatility

OptimizeRx has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Comparatively, CFN Enterprises has a beta of 0.89, meaning that its stock price is 11% less volatile than the S&P 500.

Summary

OptimizeRx beats CFN Enterprises on 9 of the 15 factors compared between the two stocks.

About OptimizeRx

(Get Free Report)

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

About CFN Enterprises

(Get Free Report)

CFN Enterprises Inc. engages in the sponsored content and marketing business in the United States. The company sets up and manages compliant and turnkey ad campaigns, as well as runs sponsored content, including articles, press releases, videos, podcasts, advertisements and other media, email advertisements, and other marketing campaigns for public and private companies. It also operates various media platforms, including CannabisFN.com, CFNMediaNews.com, and other venues to educate and inform investors interested in the cannabis industry; and distributes content across various online platforms, such as the CannabisFN.com website, press releases, financial news syndicates, search engines, YouTube, iTunes, Instagram, X, Facebook, LinkedIn, and others. In addition, the company is involved in the white label manufacturing and co-packing business; and cannabidiol manufacturing business. It serves cannabis, hemp, and wellness industries. The company was formerly known as Accelerize Inc. and changed its name to CFN Enterprises Inc. in October 2019. CFN Enterprises Inc. was founded in 2001 and is based in Whitefish, Montana.

Receive News & Ratings for OptimizeRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptimizeRx and related companies with MarketBeat.com's FREE daily email newsletter.